Active FLT3 binds to ABL2

Stable Identifier
R-HSA-9706287
Type
Reaction [binding]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

The Abelson (ABL) family of non-receptor tyrosine kinase 2 (ABL2, also known as ARG) binds to tyrosine phosphorylated FLT3. ABL2 binding inhibits FLT3-dependent AKT signaling without affecting other downstream pathways like the MAP kinase and STAT cascades, and without affecting FLT3 phosphorylation or stability. The mechanism for ABL2-mediated negative regulation of FLT3 AKT signaling remains to be elucidated (Kazi et al, 2017; reviewed in Kazi and Ronnstrand, 2019).

Literature References
PubMed ID Title Journal Year
28086240 ABL2 suppresses FLT3-ITD-induced cell proliferation through negative regulation of AKT signaling

Kazi, JU, Rupar, K, Marhäll, A, Moharram, SA, Khanum, F, Shah, K, Gazi, M, Nagaraj, SR, Sun, J, Chougule, RA, Rönnstrand, L

Oncotarget 2017
Participants
Participant Of
Orthologous Events
Authored
Reviewed
Created
Cite Us!